TRK Inhibition: A New Tumor-Agnostic Treatment Strategy

Targeted Oncology - France
doi 10.1007/s11523-018-0590-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Tumor-Agnostic Therapy Gets on TRK

Science
MultidisciplinaryPhilosophy of ScienceHistory
2018English

Reducing Inhibition: A Promising New Strategy for the Treatment of Schizophrenia

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2018English

Acute Otitis Media: A New Treatment Strategy

BMJ
1985English

DDR1 Inhibition as a New Therapeutic Strategy for Colorectal Cancer

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2018English

Discovery of GNF-5837, a Selective TRK Inhibitor With Efficacy in Rodent Cancer Tumor Models

ACS Medicinal Chemistry Letters
Organic ChemistryBiochemistryDrug Discovery
2012English

Inhibition of Receptor for Advanced Glycation End Products as New Promising Strategy Treatment in Diabetic Retinopathy

Open Access Macedonian Journal of Medical Sciences
Medicine
2019English

A New Treatment Strategy for Advanced Idiopathic Interstitial Pneumonia

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Early Prediction of Tumor Response: A Future Strategy for Optimizing Cancer Treatment

2013English

Inhibition of Tau Phosphorylation as a Potential Strategy in Treatment of Parkinson’s Disease

2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy